Albers Jeffrey W. - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (SYRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 24, 2023, Albers Jeffrey W.'s relationship to Spyre Therapeutics, Inc. (SYRE) is Director, and currently has 34,360 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRE insiders.
Data Source: SEC.
Albers Jeffrey W. - Insider Non-Derivative Transactions at SYRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 25, 2023 | C -- (Common Stock) | 34360 | 0 | 34360 |